| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
|
Am Heart J
|
2015
|
1.57
|
|
2
|
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
|
Am Heart J
|
2013
|
0.95
|
|
3
|
Comparative Effectiveness of Hybrid Coronary Revascularization vs Coronary Artery Bypass Grafting.
|
J Am Coll Surg
|
2015
|
0.93
|
|
4
|
Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012.
|
Am Heart J
|
2014
|
0.92
|
|
5
|
Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
|
Am Heart J
|
2014
|
0.87
|
|
6
|
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
|
Am Heart J
|
2014
|
0.85
|
|
7
|
Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
|
Am Heart J
|
2015
|
0.83
|
|
8
|
Patient-Centered Research into Outcomes Stroke Patients Prefer and Effectiveness Research: Implementing the patient-driven research paradigm to aid decision making in stroke care.
|
Am Heart J
|
2015
|
0.83
|
|
9
|
Outcomes Associated With Familial Versus Nonfamilial Atrial Fibrillation: A Matched Nationwide Cohort Study.
|
J Am Heart Assoc
|
2016
|
0.81
|
|
10
|
Trends in outcomes among older patients with non-ST-segment elevation myocardial infarction.
|
Am Heart J
|
2013
|
0.80
|
|
11
|
Association of hospital myocardial infarction volume with adherence to American College of Cardiology/American Heart Association performance measures: Insights from the National Cardiovascular Data Registry.
|
Am Heart J
|
2016
|
0.79
|
|
12
|
Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus.
|
Am Heart J
|
2014
|
0.78
|
|
13
|
Patient adherence to generic versus brand statin therapy after acute myocardial infarction: Insights from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the American College of Cardiology/American Heart Association Guidelines Registry.
|
Am Heart J
|
2015
|
0.78
|
|
14
|
Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease.
|
Am Heart J
|
2015
|
0.77
|
|
15
|
Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
|
J Am Heart Assoc
|
2016
|
0.77
|
|
16
|
Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
|
Am Heart J
|
2016
|
0.77
|
|
17
|
Implications of prior myocardial infarction for patients presenting with an acute myocardial infarction.
|
Am Heart J
|
2014
|
0.77
|
|
18
|
Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non-ST-segment elevation acute coronary syndrome.
|
Am Heart J
|
2014
|
0.76
|
|
19
|
Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.
|
Am Heart J
|
2016
|
0.76
|
|
20
|
The association of in-hospital guideline adherence and longitudinal postdischarge mortality in older patients with non-ST-segment elevation myocardial infarction.
|
Am Heart J
|
2015
|
0.76
|
|
21
|
Current quality of cardiovascular prevention for Million Hearts: an analysis of 147,038 outpatients from The Guideline Advantage.
|
Am Heart J
|
2014
|
0.76
|
|
22
|
Healthcare Resource Availability, Quality of Care, and Acute Ischemic Stroke Outcomes.
|
J Am Heart Assoc
|
2017
|
0.75
|
|
23
|
Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial".
|
Circulation
|
2016
|
0.75
|
|
24
|
Outcomes According to Cardiac Catheterization Referral and Clopidogrel Use Among Medicare Patients With Non-ST-Segment Elevation Myocardial Infarction Discharged Without In-hospital Revascularization.
|
J Am Heart Assoc
|
2016
|
0.75
|
|
25
|
Response to letter regarding article, "The learning curve for transradial percutaneous coronary intervention among operators in the United States: a study from the National Cardiovascular Data Registry".
|
Circulation
|
2015
|
0.75
|
|
26
|
Defining a Mobile Health Roadmap for Cardiovascular Health and Disease.
|
J Am Heart Assoc
|
2016
|
0.75
|
|
27
|
Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry.
|
Am Heart J
|
2017
|
0.75
|
|
28
|
Variation in performance measure criteria significantly affects cardiology practice rankings: Insights from the National Cardiovascular Data Registry's Practice Innovation and Clinical Excellence Registry.
|
Am Heart J
|
2015
|
0.75
|
|
29
|
Supporting open access to clinical trial data for researchers: The Duke Clinical Research Institute-Bristol-Myers Squibb Supporting Open Access to Researchers Initiative.
|
Am Heart J
|
2015
|
0.75
|
|
30
|
Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation.
|
Am J Med
|
2016
|
0.75
|
|
31
|
Impact of an Expanded Hospital Recognition Program for Stroke Quality of Care.
|
J Am Heart Assoc
|
2017
|
0.75
|
|
32
|
Association of measured platelet reactivity with changes in P2Y12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study.
|
Am Heart J
|
2017
|
0.75
|
|
33
|
Targeted versus standard feedback: results from a randomized quality improvement trial.
|
Am Heart J
|
2014
|
0.75
|
|
34
|
A nationwide survey on perception, experience, and expectations of hybrid coronary revascularization among top-ranked US hospitals.
|
Am Heart J
|
2015
|
0.75
|
|
35
|
Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study.
|
Am Heart J
|
2016
|
0.75
|
|
36
|
Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
|
J Am Heart Assoc
|
2017
|
0.75
|
|
37
|
The quality of antiplatelet and anticoagulant medication administration among ST-segment elevation myocardial infarction patients transferred for primary percutaneous coronary intervention.
|
Am Heart J
|
2014
|
0.75
|
|
38
|
Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction.
|
Am Heart J
|
2015
|
0.75
|